Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice

Fumitake Saito, Sadatomo Tasaka, Ken Ichiro Inoue, Keisuke Miyamoto, Yasushi Nakano, Yuko Ogawa, Wakako Yamasawa, Yoshiki Shiraishi, Naoki Hasegawa, Seitaro Fujishima, Hirohisa Takano, Akitoshi Ishizaka

研究成果: Article

104 引用 (Scopus)

抄録

Interleukin-6 (IL-6) is known to be involved in the pathogenesis of various inflammatory diseases, but its role in bleomycin (BLM)-induced lung injury and subsequent fibrotic changes remains to be determined. We evaluated the role of IL-6 in the lung inflammatory changes induced by BLM using wild-type (WT) and IL-6-deficient (IL-6-/-) mice. The mice were treated intratracheally with 1 mg/kg BLM and killed 2, 7, or 21 days later. Lung Inflammation in the acute phase (Days 2 and 7) was assessed by differential cell counts in bronchoalveolar lavage (BAL) fluid and cytokine levels in the lung. Lung fibrotic changes were evaluated on Day 21 by histopathology and collagen assay. On Day 2, BLM administration induced significant increases in the numbers of total cells, macrophages, and neutrophils in BAL fluid, which were attenuated in IL-6-/- mice (P < 0.05). Lung pathology also showed inflammatory cell accumulation, which was attenuated in the IL-6-/- mice compared with WT mice. In WT mice, elevated levels of TGF-b1 and CCL3 were observed 2 and 7 days after BLM challenge, respectively. On Day 7, BLM-induced inflammatory cell accumulation did not differ between the genotypes. Lung pathology 21 days after BLM challenge revealed significant fibrotic changes with increased collagen content, which was attenuated in IL-6-/- mice. Although the TGF-β1 level in the lung did not differ between the genotypes on Day 21, CCL3 was significantly lower in IL-6-/- mice. These results indicate that IL-6 may play an important role in the pathogenesis of BLM-induced lung injury and subsequent fibrotic changes.

元の言語English
ページ(範囲)566-571
ページ数6
ジャーナルAmerican Journal of Respiratory Cell and Molecular Biology
38
発行部数5
DOI
出版物ステータスPublished - 2008 5 1

Fingerprint

Bleomycin
Interleukin-6
Lung
Bronchoalveolar Lavage Fluid
Lung Injury
Pathology
Collagen
Cell Count
Genotype
Fluids
Macrophages
indium-bleomycin
Pneumonia
Neutrophils
mouse interleukin-6
Assays
Cytokines

ASJC Scopus subject areas

  • Cell Biology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology

これを引用

Saito, F., Tasaka, S., Inoue, K. I., Miyamoto, K., Nakano, Y., Ogawa, Y., ... Ishizaka, A. (2008). Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. American Journal of Respiratory Cell and Molecular Biology, 38(5), 566-571. https://doi.org/10.1165/rcmb.2007-0299OC

Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. / Saito, Fumitake; Tasaka, Sadatomo; Inoue, Ken Ichiro; Miyamoto, Keisuke; Nakano, Yasushi; Ogawa, Yuko; Yamasawa, Wakako; Shiraishi, Yoshiki; Hasegawa, Naoki; Fujishima, Seitaro; Takano, Hirohisa; Ishizaka, Akitoshi.

:: American Journal of Respiratory Cell and Molecular Biology, 巻 38, 番号 5, 01.05.2008, p. 566-571.

研究成果: Article

Saito, F, Tasaka, S, Inoue, KI, Miyamoto, K, Nakano, Y, Ogawa, Y, Yamasawa, W, Shiraishi, Y, Hasegawa, N, Fujishima, S, Takano, H & Ishizaka, A 2008, 'Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice', American Journal of Respiratory Cell and Molecular Biology, 巻. 38, 番号 5, pp. 566-571. https://doi.org/10.1165/rcmb.2007-0299OC
Saito, Fumitake ; Tasaka, Sadatomo ; Inoue, Ken Ichiro ; Miyamoto, Keisuke ; Nakano, Yasushi ; Ogawa, Yuko ; Yamasawa, Wakako ; Shiraishi, Yoshiki ; Hasegawa, Naoki ; Fujishima, Seitaro ; Takano, Hirohisa ; Ishizaka, Akitoshi. / Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. :: American Journal of Respiratory Cell and Molecular Biology. 2008 ; 巻 38, 番号 5. pp. 566-571.
@article{2b11c2e40ac04301891e10c2211ecbf6,
title = "Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice",
abstract = "Interleukin-6 (IL-6) is known to be involved in the pathogenesis of various inflammatory diseases, but its role in bleomycin (BLM)-induced lung injury and subsequent fibrotic changes remains to be determined. We evaluated the role of IL-6 in the lung inflammatory changes induced by BLM using wild-type (WT) and IL-6-deficient (IL-6-/-) mice. The mice were treated intratracheally with 1 mg/kg BLM and killed 2, 7, or 21 days later. Lung Inflammation in the acute phase (Days 2 and 7) was assessed by differential cell counts in bronchoalveolar lavage (BAL) fluid and cytokine levels in the lung. Lung fibrotic changes were evaluated on Day 21 by histopathology and collagen assay. On Day 2, BLM administration induced significant increases in the numbers of total cells, macrophages, and neutrophils in BAL fluid, which were attenuated in IL-6-/- mice (P < 0.05). Lung pathology also showed inflammatory cell accumulation, which was attenuated in the IL-6-/- mice compared with WT mice. In WT mice, elevated levels of TGF-b1 and CCL3 were observed 2 and 7 days after BLM challenge, respectively. On Day 7, BLM-induced inflammatory cell accumulation did not differ between the genotypes. Lung pathology 21 days after BLM challenge revealed significant fibrotic changes with increased collagen content, which was attenuated in IL-6-/- mice. Although the TGF-β1 level in the lung did not differ between the genotypes on Day 21, CCL3 was significantly lower in IL-6-/- mice. These results indicate that IL-6 may play an important role in the pathogenesis of BLM-induced lung injury and subsequent fibrotic changes.",
keywords = "Bleomycin, CCL3, Fibrosis, IL-6, TGF-β",
author = "Fumitake Saito and Sadatomo Tasaka and Inoue, {Ken Ichiro} and Keisuke Miyamoto and Yasushi Nakano and Yuko Ogawa and Wakako Yamasawa and Yoshiki Shiraishi and Naoki Hasegawa and Seitaro Fujishima and Hirohisa Takano and Akitoshi Ishizaka",
year = "2008",
month = "5",
day = "1",
doi = "10.1165/rcmb.2007-0299OC",
language = "English",
volume = "38",
pages = "566--571",
journal = "American Journal of Respiratory Cell and Molecular Biology",
issn = "1044-1549",
publisher = "American Thoracic Society",
number = "5",

}

TY - JOUR

T1 - Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice

AU - Saito, Fumitake

AU - Tasaka, Sadatomo

AU - Inoue, Ken Ichiro

AU - Miyamoto, Keisuke

AU - Nakano, Yasushi

AU - Ogawa, Yuko

AU - Yamasawa, Wakako

AU - Shiraishi, Yoshiki

AU - Hasegawa, Naoki

AU - Fujishima, Seitaro

AU - Takano, Hirohisa

AU - Ishizaka, Akitoshi

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Interleukin-6 (IL-6) is known to be involved in the pathogenesis of various inflammatory diseases, but its role in bleomycin (BLM)-induced lung injury and subsequent fibrotic changes remains to be determined. We evaluated the role of IL-6 in the lung inflammatory changes induced by BLM using wild-type (WT) and IL-6-deficient (IL-6-/-) mice. The mice were treated intratracheally with 1 mg/kg BLM and killed 2, 7, or 21 days later. Lung Inflammation in the acute phase (Days 2 and 7) was assessed by differential cell counts in bronchoalveolar lavage (BAL) fluid and cytokine levels in the lung. Lung fibrotic changes were evaluated on Day 21 by histopathology and collagen assay. On Day 2, BLM administration induced significant increases in the numbers of total cells, macrophages, and neutrophils in BAL fluid, which were attenuated in IL-6-/- mice (P < 0.05). Lung pathology also showed inflammatory cell accumulation, which was attenuated in the IL-6-/- mice compared with WT mice. In WT mice, elevated levels of TGF-b1 and CCL3 were observed 2 and 7 days after BLM challenge, respectively. On Day 7, BLM-induced inflammatory cell accumulation did not differ between the genotypes. Lung pathology 21 days after BLM challenge revealed significant fibrotic changes with increased collagen content, which was attenuated in IL-6-/- mice. Although the TGF-β1 level in the lung did not differ between the genotypes on Day 21, CCL3 was significantly lower in IL-6-/- mice. These results indicate that IL-6 may play an important role in the pathogenesis of BLM-induced lung injury and subsequent fibrotic changes.

AB - Interleukin-6 (IL-6) is known to be involved in the pathogenesis of various inflammatory diseases, but its role in bleomycin (BLM)-induced lung injury and subsequent fibrotic changes remains to be determined. We evaluated the role of IL-6 in the lung inflammatory changes induced by BLM using wild-type (WT) and IL-6-deficient (IL-6-/-) mice. The mice were treated intratracheally with 1 mg/kg BLM and killed 2, 7, or 21 days later. Lung Inflammation in the acute phase (Days 2 and 7) was assessed by differential cell counts in bronchoalveolar lavage (BAL) fluid and cytokine levels in the lung. Lung fibrotic changes were evaluated on Day 21 by histopathology and collagen assay. On Day 2, BLM administration induced significant increases in the numbers of total cells, macrophages, and neutrophils in BAL fluid, which were attenuated in IL-6-/- mice (P < 0.05). Lung pathology also showed inflammatory cell accumulation, which was attenuated in the IL-6-/- mice compared with WT mice. In WT mice, elevated levels of TGF-b1 and CCL3 were observed 2 and 7 days after BLM challenge, respectively. On Day 7, BLM-induced inflammatory cell accumulation did not differ between the genotypes. Lung pathology 21 days after BLM challenge revealed significant fibrotic changes with increased collagen content, which was attenuated in IL-6-/- mice. Although the TGF-β1 level in the lung did not differ between the genotypes on Day 21, CCL3 was significantly lower in IL-6-/- mice. These results indicate that IL-6 may play an important role in the pathogenesis of BLM-induced lung injury and subsequent fibrotic changes.

KW - Bleomycin

KW - CCL3

KW - Fibrosis

KW - IL-6

KW - TGF-β

UR - http://www.scopus.com/inward/record.url?scp=42949157763&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949157763&partnerID=8YFLogxK

U2 - 10.1165/rcmb.2007-0299OC

DO - 10.1165/rcmb.2007-0299OC

M3 - Article

C2 - 18096870

AN - SCOPUS:42949157763

VL - 38

SP - 566

EP - 571

JO - American Journal of Respiratory Cell and Molecular Biology

JF - American Journal of Respiratory Cell and Molecular Biology

SN - 1044-1549

IS - 5

ER -